Hansoh Pharma hits 4-1/2-year peak on higher profit, dividend

Hansoh Pharmaceutical

19/08/2025 04:47

** Shares of Hansoh Pharmaceutical Group 3692.HK rise 7.3% to HK$39.76, hitting their highest point since March 2021, and on course to snap three straight sessions of declines

** Stock on track for its biggest one-day pct gain since February 21

** Co says H1 net profit rises 15% y/y, revenue up 14.3%

** Declares an interim dividend of HK$0.2316 per share, up from HK$0.2010 apiece a year earlier

** Nomura maintains "neutral" rating but lifts TP to HK$35.47 from HK$31.82, saying first-half results beat on higher collaboration revenue

** Nomura raises revenue and earnings forecasts for Hansoh

** The Hang Seng Biotech Index .HSHKBIO eases 0.9%, the benchmark Hang Seng Index .HSI slips 0.04%

** YTD, stock has more than doubled in value

 (Reporting by Donny Kwok)

 ((donny.kwok@thomsonreuters.com))